D. García

Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.

J. Esteve, S. Mercadal, M. Tormo, 2018, Leukemia research.

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study

M. Tormo, M. Sanz, J. Labrador, 2021, Blood advances.

Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status

J. Esteve, M. Tormo, J. Hernández-Rivas, 2013, Cancer.

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era

Juan F. García, A. López-Guillermo, A. Salar, 2019, European journal of haematology.

New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma treated with R‐CHOP: Spanish Lymphoma Group Experience (GELTAMO)

A. Salar, P. Abrisqueta, J. Sancho, 2019, British journal of haematology.

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

P. Abrisqueta, S. Mercadal, J. Sancho, 2019, Blood.